- Home
- AUPH vs CSR Comparison
AUPH vs CSR Comparison
Compare AUPH & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- CSR
- Stock Information
- Founded
- AUPH 1993
- CSR 1970
- Country
- AUPH Canada
- CSR United States
- Employees
- AUPH N/A
- CSR N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- CSR Real Estate Investment Trusts
- Sector
- AUPH Health Care
- CSR Real Estate
- Exchange
- AUPH Nasdaq
- CSR Nasdaq
- Market Cap
- AUPH 1.0B
- CSR 1.1B
- IPO Year
- AUPH 1999
- CSR N/A
- Fundamental
- Price
- AUPH $8.12
- CSR $72.85
- Analyst Decision
- AUPH Strong Buy
- CSR Buy
- Analyst Count
- AUPH 3
- CSR 6
- Target Price
- AUPH $10.33
- CSR $71.40
- AVG Volume (30 Days)
- AUPH 1.3M
- CSR 118.3K
- Earning Date
- AUPH 11-07-2024
- CSR 10-28-2024
- Dividend Yield
- AUPH N/A
- CSR 4.14%
- EPS Growth
- AUPH N/A
- CSR N/A
- EPS
- AUPH N/A
- CSR N/A
- Revenue
- AUPH $220,361,000.00
- CSR $258,642,000.00
- Revenue This Year
- AUPH $36.52
- CSR N/A
- Revenue Next Year
- AUPH $19.02
- CSR $3.96
- P/E Ratio
- AUPH N/A
- CSR N/A
- Revenue Growth
- AUPH 38.72
- CSR N/A
- 52 Week Low
- AUPH $4.71
- CSR $20.10
- 52 Week High
- AUPH $10.05
- CSR $76.16
- Technical
- Relative Strength Index (RSI)
- AUPH 62.64
- CSR 54.41
- Support Level
- AUPH $8.06
- CSR $72.20
- Resistance Level
- AUPH $8.70
- CSR $75.92
- Average True Range (ATR)
- AUPH 0.34
- CSR 2.11
- MACD
- AUPH 0.07
- CSR 0.39
- Stochastic Oscillator
- AUPH 63.74
- CSR 67.01
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and they conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.